Zobrazeno 1 - 10
of 56
pro vyhledávání: '"MESH: Cytotoxicity, Immunologic"'
Autor:
Susannah Williams, Alberto Nassi, Philippe Hantraye, Aurore Bugi, Marie Michael, Sophie Lecourtois, Caroline Jan, Emanuele Cozzi, Antoine Blancher, Anselme L. Perrier, Romina Aron Badin, Marta Vadori
Publikováno v:
Nature Communications
Nature Communications, In press, 10, pp.4357. ⟨10.1038/s41467-019-12324-0⟩
Nature Communications, Nature Publishing Group, 2019, 10, pp.4357. ⟨10.1038/s41467-019-12324-0⟩
Nature Communications, Vol 10, Iss 1, Pp 1-12 (2019)
Nature Communications, In press, 10, pp.4357. ⟨10.1038/s41467-019-12324-0⟩
Nature Communications, Nature Publishing Group, 2019, 10, pp.4357. ⟨10.1038/s41467-019-12324-0⟩
Nature Communications, Vol 10, Iss 1, Pp 1-12 (2019)
Cell therapy products (CTP) derived from pluripotent stem cells (iPSCs) may constitute a renewable, specifically differentiated source of cells to potentially cure patients with neurodegenerative disorders. However, the immunogenicity of CTP remains
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::588ddf3c7a3ff145b06c0db45b983fe1
https://hal-cea.archives-ouvertes.fr/cea-02997553
https://hal-cea.archives-ouvertes.fr/cea-02997553
Autor:
Frédéric Tangy, Thierry Huet, Pierre Langlade-Demoyen, Christelle Liard, Marion Julithe, Marie Escande, Chantal Combredet, Jessie Thalmensi, Simon Wain-Hobson, Elodie Pliquet, Claude Ruffié, Thomas Bestetti, Valérie Najburg
Publikováno v:
Cancer Immunology, Immunotherapy
Cancer Immunology, Immunotherapy, 2019, 68 (4), pp.533-544. ⟨10.1007/s00262-018-2272-3⟩
Cancer Immunology, Immunotherapy, Springer Verlag, 2019, 68 (4), pp.533-544. ⟨10.1007/s00262-018-2272-3⟩
Cancer Immunology, Immunotherapy, 2019, 68 (4), pp.533-544. ⟨10.1007/s00262-018-2272-3⟩
Cancer Immunology, Immunotherapy, Springer Verlag, 2019, 68 (4), pp.533-544. ⟨10.1007/s00262-018-2272-3⟩
International audience; Cancer immunotherapy is seeing an increasing focus on vaccination with tumor-associated antigens (TAAs). Human telomerase (hTERT) is a TAA expressed by most tumors to overcome telomere shortening. Tolerance to hTERT can be eas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f044afa53550131a805a172fa5811146
https://hal-pasteur.archives-ouvertes.fr/pasteur-03232227
https://hal-pasteur.archives-ouvertes.fr/pasteur-03232227
Autor:
James P. Di Santo, Sophia Maschalidi, Fernando E. Sepulveda, Geneviève de Saint Basile, Gaël Ménasché, Alain Fischer, Christian A. J. Vosshenrich, Mathieu Kurowska, Alexandrine Garrigue
Publikováno v:
Blood
Blood, American Society of Hematology, 2015, 125 (9), pp.1427-34. ⟨10.1182/blood-2014-09-602946⟩
Blood, 2015, 125 (9), pp.1427-34. ⟨10.1182/blood-2014-09-602946⟩
Blood, American Society of Hematology, 2015, 125 (9), pp.1427-1434. ⟨10.1182/blood-2014-09-602946⟩
Blood, American Society of Hematology, 2015, 125 (9), pp.1427-34. ⟨10.1182/blood-2014-09-602946⟩
Blood, 2015, 125 (9), pp.1427-34. ⟨10.1182/blood-2014-09-602946⟩
Blood, American Society of Hematology, 2015, 125 (9), pp.1427-1434. ⟨10.1182/blood-2014-09-602946⟩
International audience; The impairment of cytotoxic activity of lymphocytes disturbs immune surveillance and leads to the development of hemophagocytic lymphohistiocytic syndrome (HLH). Although cytotoxic T lymphocyte (CTL) control of HLH development
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c775810d37acc20400567fa4d50a93ae
https://doi.org/10.1182/blood-2014-09-602946
https://doi.org/10.1182/blood-2014-09-602946
Autor:
Thornton W Thompson, David H. Raulet, Yann M. Kerdiles, Pierre Bruhns, Stephen L. Nutt, Eric Vivier, Margaux Vienne, Gabrielle T. Belz, Nicholas D. Huntington, Francisca F. Almeida, Michael Chopin
Publikováno v:
Immunity
Immunity, 2017, 47 (2), pp.199-200. ⟨10.1016/j.immuni.2017.07.026⟩
Immunity, Elsevier, 2017, 47 (2), pp.199-200. ⟨10.1016/j.immuni.2017.07.026⟩
Immunity, vol 47, iss 2
Kerdiles, YM; Almeida, FF; Thompson, T; Chopin, M; Vienne, M; Bruhns, P; et al.(2017). Natural-Killer-like B Cells Display the Phenotypic and Functional Characteristics of Conventional B Cells. Immunity, 47(2), 199-200. doi: 10.1016/j.immuni.2017.07.026. UC Berkeley: Retrieved from: http://www.escholarship.org/uc/item/41b4b8h3
Immunity, 2017, 47 (2), pp.199-200. ⟨10.1016/j.immuni.2017.07.026⟩
Immunity, Elsevier, 2017, 47 (2), pp.199-200. ⟨10.1016/j.immuni.2017.07.026⟩
Immunity, vol 47, iss 2
Kerdiles, YM; Almeida, FF; Thompson, T; Chopin, M; Vienne, M; Bruhns, P; et al.(2017). Natural-Killer-like B Cells Display the Phenotypic and Functional Characteristics of Conventional B Cells. Immunity, 47(2), 199-200. doi: 10.1016/j.immuni.2017.07.026. UC Berkeley: Retrieved from: http://www.escholarship.org/uc/item/41b4b8h3
Author(s): Kerdiles, Yann M; Almeida, Francisca F; Thompson, Thornton; Chopin, Michael; Vienne, Margaux; Bruhns, Pierre; Huntington, Nicholas D; Raulet, David H; Nutt, Stephen L; Belz, Gabrielle T; Vivier, Eric
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5ba621e7c984d39a0f87c781469c179
https://europepmc.org/articles/PMC5705200/
https://europepmc.org/articles/PMC5705200/
Autor:
Bianca Balbino, George Delidakis, Tae Hyun Kang, Makiko Watanabe, Kendra Triplett, Anja Lux, Navin Varadarajan, Odile Richard-Le Goff, Oana I. Lungu, Pierre Bruhns, George Georgiou, Corrine Alford, Gabrielle Romain, Margaret A. Lindorfer, Wissam Charab, Falk Nimmerjahn, Yan Jessie Zhang, Hidetaka Tanno, Wupeng Yan, Nicholas M. Marshall, Moses Donkor, Chang-Han Lee, Jiwon Lee, Ronald P. Taylor, Biliana Todorova
Publikováno v:
Nature Immunology
Nature Immunology, Nature Publishing Group, 2017, 18 (8), pp.889-898. ⟨10.1038/ni.3770⟩
Nature Immunology, 2017, 18 (8), pp.889-898. ⟨10.1038/ni.3770⟩
Nature Immunology, Nature Publishing Group, 2017, 18 (8), pp.889-898. ⟨10.1038/ni.3770⟩
Nature Immunology, 2017, 18 (8), pp.889-898. ⟨10.1038/ni.3770⟩
International audience; Engineered crystallizable fragment (Fc) regions of antibody domains, which assume a unique and unprecedented asymmetric structure within the homodimeric Fc polypeptide, enable completely selective binding to the complement com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3d0740466da17325dc05af13c9b0b13
https://hal-pasteur.archives-ouvertes.fr/pasteur-02510289
https://hal-pasteur.archives-ouvertes.fr/pasteur-02510289
Autor:
S. Brunelle, Mélanie Bentobji, Alessandro Moretta, Samuel Granjeaud, Gwenaelle Gravis, Flora Poizat, N. Salem, Palma Rocchi, Daniel Olive, Mathilde Guerin, Jeanne Thomassin-Piana, Francine Azario-Cheillan, Jochen Walz, Christine Pasero, Maria Paciencia-Gros
Publikováno v:
Cancer Research
Cancer Research, American Association for Cancer Research, 2016, 76 (8), pp.2153-2165. ⟨10.1158/0008-5472.CAN-15-1965⟩
Cancer Research, 2016, 76 (8), pp.2153-2165. ⟨10.1158/0008-5472.CAN-15-1965⟩
Cancer Research, American Association for Cancer Research, 2016, 76 (8), pp.2153-2165. ⟨10.1158/0008-5472.CAN-15-1965⟩
Cancer Research, 2016, 76 (8), pp.2153-2165. ⟨10.1158/0008-5472.CAN-15-1965⟩
The field of immunotherapy for solid tumors, such as prostate cancer, has been recently focusing on therapies that can counter tumor-mediated immunosuppression. Precise quantification and characterization of the immune infiltrates in tumors is crucia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84b06be2cbc33750fe166609bb2e9c72
https://hal.archives-ouvertes.fr/hal-03599185
https://hal.archives-ouvertes.fr/hal-03599185
Autor:
Suzanne Peyrottes, Eric Champagne, Charline Daguzan, Christian Davrinche, Morgane Moulin, Hanna Kulyk-Barbier
Publikováno v:
Journal of Immunology
Journal of Immunology, Publisher : Baltimore : Williams & Wilkins, c1950-. Latest Publisher : Bethesda, MD : American Association of Immunologists, 2016, 196 (5), pp.2219-2229. ⟨10.4049/jimmunol.1501661⟩
Journal of Immunology, 2016, 196 (5), pp.2219-2229. ⟨10.4049/jimmunol.1501661⟩
Journal of Immunology, Publisher : Baltimore : Williams & Wilkins, c1950-. Latest Publisher : Bethesda, MD : American Association of Immunologists, 2016, 196 (5), pp.2219-2229. ⟨10.4049/jimmunol.1501661⟩
Journal of Immunology, 2016, 196 (5), pp.2219-2229. ⟨10.4049/jimmunol.1501661⟩
Human V gamma 9V delta 2 T cells are activated through their TCR by neighboring cells producing phosphoantigens. Zoledronate (ZOL) treatment induces intracellular accumulation of the phosphoantigens isopentenyl pyrophosphate and ApppI. Few attempts h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bb90cf91f93a97be4d52664ed4c92bf
https://hal.archives-ouvertes.fr/hal-02408121
https://hal.archives-ouvertes.fr/hal-02408121
Autor:
Françoise Raynaud, Yves Lepelletier, Olivier Hermine, Réda Hadj-Slimane, Christophe Gras, Claudine Pique, Jean-Philippe Herbeuval, Lucie Barblu, Renaud Colisson
Publikováno v:
Blood
Blood, American Society of Hematology, 2010, 115 (11), pp.2177-2185. ⟨10.1182/blood-2009-06-224741⟩
Blood, American Society of Hematology, 2010, 115, pp.2177-2185
Blood, American Society of Hematology, 2010, 115 (11), pp.2177-2185. ⟨10.1182/blood-2009-06-224741⟩
Blood, American Society of Hematology, 2010, 115, pp.2177-2185
A recent report demonstrated that free human T-cell leukemia virus 1 (HTLV-1) could infect plasmacytoid dendritic cells (pDCs). The major role of pDCs is to secrete massive levels of interferon-α (IFN-α) upon virus exposure; however, the induction
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25de7426d0b463328339c189bc5c1cbd
https://doi.org/10.1182/blood-2009-06-224741
https://doi.org/10.1182/blood-2009-06-224741
Publikováno v:
European Journal of Immunology
European Journal of Immunology, Wiley-VCH Verlag, 2009, 39 (4), pp.1025-35. ⟨10.1002/eji.200838929⟩
European Journal of Immunology, Wiley-VCH Verlag, 2009, 39 (4), pp.1025-35. ⟨10.1002/eji.200838929⟩
International audience; Human invariant NKT (iNKT) cells are a unique subset of T cells, which recognize glycolipids presented by the CD1d. Among the iNKT cells, several functionally distinct subsets have been characterized according to CD4 and/or CD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::412a39fb595ad3847691ae118d42c3fc
https://doi.org/10.1002/eji.200838929
https://doi.org/10.1002/eji.200838929
Autor:
Hélène Rouard, Coralie Chaise, Hans J. Stauss, Jason Rice, Valérie Molinier-Frenkel, Freda K. Stevenson, Sarah L. Buchan, Jeanine Marquet, Marie-Hélène Delfau-Larue, Mathieu Kuentz, Jean-Pierre Farcet, Gisella E. Vittes
Publikováno v:
Blood
Blood, American Society of Hematology, 2008, 112 (7), pp.2956-64. ⟨10.1182/blood-2008-02-137695⟩
Blood, American Society of Hematology, 2008, 112 (7), pp.2956-64. ⟨10.1182/blood-2008-02-137695⟩
The Wilms tumor antigen, WT1, is associated with several human cancers, including leukemia. We evaluated WT1 as an immunotherapeutic target using our proven DNA fusion vaccine design, p.DOM-peptide, encoding a minimal tumor-derived major histocompati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e9e463aa17f269966bf6878c8eab94e
https://doi.org/10.1182/blood-2008-02-137695
https://doi.org/10.1182/blood-2008-02-137695